SHIELD

Dhiraj Namdev
Rain Blossom
Uma Deepthi Yalla

NITIE Mumbai
How interactions in the pharma ecosystem have changed, Pre- and Post-CoViD-19?

No of weekly patients visits ,thousands Average weekly patient consultation by type

180
120
160
140 100
120
80
100
80 60
60 40
40
20
20
0 0
feb 10-16 feb 17-23 feb 24-Mar Mar 2-8 Mar 9-15 Mar 16-22 Mar 22-29 Pre Crisis Now At Peak Crisis 6 Months Post
1
Crisis

Onocology(-14%) Dermotology(-43%) cardiology(-31%) In Person Consultation Remote Consultation

The COVID-19 has dramatically reduced the number of patients seeing HCPs, because fewer patients are visiting HCPs for non COVID-19 related problems
 Short Term Strategy

Using the existing videoconferencing apps Enhancing the current increase of remote
and establishing the relationships working tools for measuring potential vitals
between HCPs & Patients. & increasing the sales of tools steadily by
Videoconferencing
Also, 87% of HCPs want either all virtual between HCPs and Remote working tools providing some discounts
or a mix of virtual and in-person meetings patients for health such as sensors for
even after the pandemic ends check ups and remote measuring patient vitals
treatment

Electronic health record

Virtual interaction of
to enable patients to
HCPs and pharma
access their recorded
companies for not just
As, 65% of meetings with pharma reps health history or for 17% savings have been demonstrated
product information but
are now being held virtually, additional HCPs to check on when provided virtual care with their
also for additional value
patients in post-visit
value additional services like latest added services existing healthcare professionals instead
follow-up
content, using existing media for of using an outsourced provider.
enhancing the relationship & giving Using Data Analytics combined with
discounts for loyalty inventory management can be helpful for
maintaining the appropriate level of
stocks.
Long Term Strategy (Areas to look for the next 2 years)
1. Point of Care Diagnostics
GSK to develop ‘Breath of Life App’
for India which will detect not only
COPD patients but also for other
respiratory disease as well .
These would be helpful at airports &
hospitals.
05
5.Creating Patient Awareness
& Education Platform
Creating Awareness & Education
Program by linking through Netflix for
the Rexr which would attract both
HCPs and patients on the same
platform
04
4. Developing affordable
medical devices
While giving boost to the ‘Make In India’ low-cost
medical devices like ventilator & ophthalmology
for screening & detection of diabetic retinopathy
2. Telemedicine
GSK in collaboration with health care
equipments company like Philips can help
in building the Tele-ICU/e-ICU Model
01 which will help in combining the audio
visual technology, predictive analytics, data
visualization and advanced reporting
capabilities to deliver critical information to
remote caregivers serving as revenue
booster for future.
02
3. Focusing on Electrical
03
Health & Analytics
Creating analytics platforms which can
help in identifying and highlighting
emerging foci of cases of vector-borne
infections like dengue and malaria.
Collection of data will help to alert
pharmacists and would help in effective
forecasting and minimizing errors